- OUTLOOK
Fighting cancer with microbes
Scanning electron micrograph of Helicobacter pylori on the surface of the intestine. Credit: Eye of Science/SPL
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 577, S16-S18 (2020)
doi: https://doi.org/10.1038/d41586-020-00199-x
This article is part of Nature Outlook: The gut microbiome, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Coker, O. O. et al. Gut 67, 1024–1032 (2018).
Chung, L. et al. Cell Host Microbe 23, 203–214 (2018).
Arthur, J. C. et al. Science 338, 120–123 (2012).
Dejea, C. M. et al. Science 359, 592–597 (2018).
Castellarin, M. et al. Genome Res. 22, 299–306 (2012).
Kostic, A. D. et al. Genome Res. 22, 292–298 (2012).
Bullman, S. et al. Science 358, 1443–1448 (2017).
Scott, A. J. et al. Gut 68, 1624–1632 (2019).
DeFilipp, Z. et al. N. Engl. J. Med. 381, 2043–2050 (2019).
Tanoue, T. et al. Nature 565, 600–605 (2019).
Wang, Y. et al. Nature Med. 24, 1804–1808 (2018).
The hunt for a healthy microbiome
Homing in on the molecules from microbes
The complex relationship between drugs and the microbiome
Could a bacteria-stuffed pill cure autoimmune diseases?
Could the gut microbiome be linked to autism?
Rich data sets could end costly drug discovery
Therapeutic microbes to tackle disease
Diet should be a tool for researchers, not a treatment
Highlights from studies on the gut microbiome
